【Tdap (Tetanus,Diphtheria, Pertussis) Vaccine】1 dose

【Tdap (Tetanus, Diphtheria, Pertussis) Vaccine】1 dose Suitable for pregnant women and Infant caregivers

Pertussis (Whooping cough):

Pertussis is a highly infectious illness. The disease affects the airways causing severe spells of coughing that may interfere with normal breathing. The coughing is often accompanied by a “whooping” sound, hence the common name “whooping cough”. The cough may last for 1-2 months or longer. Pertussis can also cause ear infections, bronchitis which may last a long time, pneumonia, fits, brain damage and even death.
None of the ingredients in the vaccine can cause diphtheria, tetanus or whooping cough.

The CHP (Centre for HealthProtection) has recommended that pregnant women receive one dose of acellular pertussis-containing vaccine during each pregnancy as part of routine antenatal care regardless of previous vaccination and natural infection history against pertussis, as a measure to provide direct protection for infants against pertussis.

The SCVPD recommends that the vaccination can be conducted at any time in the second or third trimester, preferably before 35 weeks of gestation, for transplacental transfer of maternal vaccine-induced antibodies to the baby.

For women who have not received any pertussis-containing vaccine during pregnancy, they would still benefit by receiving one dose of a dTap or dTap-IPVvaccine as early as possible after delivery, preferably before discharge from the hospital, for indirect protection to infants.

Of note, it requires about two weeks for antibodies to develop after the vaccination and the World Health Organization (WHO) recommends that the vaccine be given preferably at least 15 days before the end of pregnancy.

**[Terms and Conditions] and [How to book] **